Dr Steven Kao is a Medical Oncologist at Chris O’Brien Lifehouse. He completed his PhD at the Asbestos Diseases Research Institute and focused his research on predictive and prognostic factors in malignant mesothelioma.
Steven has a wide clinical, translational and psychosocial research interest in thoracic cancers, including malignant mesothelioma and asbestos-related lung cancers. He has a particular interest in managing treatment-resistant tumours for these cancers with new treatments such as immunotherapy and targeted therapy.
Listen to Julie McCrossin interview Steven in our New Cancer Treatments – Immunotherapy and Targeted Therapy podcast episode.